23 March 2022 - The South Korean Government has approved the emergency use of anti-COVID-19 pill Lagevrio, the Ministry of Food and Drug Safety said Wednesday.

The medicine, developed by US pharmaceutical company MSD, is the second anti-coronavirus pill to be authorised by the country’s health officials, following the approval of Pfizer’s antiviral drug Paxlovid in December.

Read Korea Herald article